Rating Agencies
Share recommendations
Made with ❤ von BGFL
#BGFLapp * beta
Valuable background information and well-founded assessments of individual stocks are provided by the studies of the research houses. On this page, Boersengefluester.de (BGFL) provides an integrated overview of all analyst recommendations that come in via the EQS Group newsfeed - enriched with current stock charts as well as meaningful key figure tables and investor information from BGFL. Tip: You are also welcome to use the EQS newsfeed, which we have also enhanced with all the latest company news from our coverage universe.
23.08.2024 09:06AM
Study issued by NuWays AG
Nabaltec AG (von NuWays AG): BUY
BUY
Company Name:
Nabaltec AG
ISIN:
DE000A0KPPR7
Reason for the research:
Update
Recommendation:
BUY
from:
23.08.2024
Target price:
EUR 25.00
Last rating change:
Analyst:
Christian Sandherr
Strong Q2 figures // FY guidance raised; chg.Q2 sales grew 11% yoy to € 54.4m (eNuW: € 55m) thanks to 18% volume growth. Functional F [ … ]
21.08.2024 09:01AM
Study issued by NuWays AG
Nynomic AG (von NuWays AG): BUY
BUY
Company Name:
Nynomic AG
ISIN:
DE000A0MSN11
Reason for the research:
Update
Recommendation:
BUY
from:
21.08.2024
Target price:
EUR 50.00
Last rating change:
Analyst:
Christian Sandherr
Q2 prelims: Improving margins despite weak top-line; chg.
Topic: While Q2 sales was burdened by the challenging macro environment, Nynomic mana [ … ]
06.08.2024 09:01AM
Study issued by NuWays AG
LAIQON AG (von NuWays AG): BUY
BUY
Company Name:
LAIQON AG
ISIN:
DE000A12UP29
Reason for the research:
Update
Recommendation:
BUY
from:
06.08.2024
Target price:
EUR 9.10
Last rating change:
Analyst:
Henry Wendisch
LAIC token placed & mVBRB cooperation intensified; chg. PT
Last week, LAIQON successfully placed the LAIC-Token 24 as well as [ … ]
27.06.2024 09:01AM
Study issued by NuWays AG
Nabaltec AG (von NuWays AG): Kaufen
Kaufen
Further op. improvements // FY guidance conservative
Topic: Despite the recent 30% share price increase since the low in March,
Nabaltec remains on our Alpha List with the key reasons for it being (1)
further operational improvements in Q2 and a too conservative FY guidance,
(2) the promising optionality of boehmite and (3) an attractive valuat [ … ]
19.06.2024 09:01AM
Study issued by NuWays AG
LAIQON AG (von NuWays AG): Kaufen
Kaufen
High debt-to-equity conversion and successful capital increase
Topic: in May, LAIQON's 20/24 convertible showed a 80% conversion rate and
a 5.3% cash capital increase has been placed successfully at a premium.
Both capital measures underpin the investor's appetite for LAIQON's equity
story.
High debt to equity conversion: the conversion windo [ … ]
28.05.2024 09:06AM
Study issued by NuWays AG
Cantourage Group SE (von NuWays AG): Kaufen
Kaufen
Debottlenecking production capacities
Topic: Cantourage and Portocanna entered into a strategic partnership which
offers Cantourage a capital light way to increase its production capacities
significantly amid the surging demand for medical cannabis in Germany.
Legalization light is transforming the market. As of the beginning of
April, cannab [ … ]
17.05.2024 09:02AM
Study issued by NuWays AG
Cantourage Group SE (von NuWays AG): Kaufen
Kaufen
Solid FY23 and Q1'24 prelims // accelerating growth in April; chg.
Topic: Cantourage issued solid FY23 and Q1 2024 prelims, which were
impacted by slower patient growth amid the looming (at that time)
regulatory changes. Sales figures for April (following legalization light)
show a significant acceleration.
FY23 sales grew by 67% yoy to &euro [ … ]
10.05.2024 09:06AM
Study issued by NuWays AG
Nynomic AG (von NuWays AG): Kaufen
Kaufen
Solid start into FY24 despite challenging end markets
Topic: Nynomic published a solid start into the year with order intake
returning to growth for the first time since Q3 2022. Similar to FY23, this
year’s operational performance should again be back-end loaded.
Preliminary Q1 sales grew by 6.5% yoy to € 23m thanks to consolidati [ … ]
07.05.2024 09:02AM
Study issued by NuWays AG
LAIQON AG (von NuWays AG): Kaufen
Kaufen
Capital increase to secure further growth
On Saturday, LAIQON announced a cash capital increase in order to secure
further growth and expects 85% of its 20/24 convertible bond holders to
convert into equity by end of May.
The cash capital increase without subscription rights (up to 5.7% or 1.0m
shares) priced at € 6.25 per share should [ … ]
06.05.2024 09:01AM
Study issued by NuWays AG
elumeo SE (von NuWays AG): Halten
Halten
Mixed Q4 // Weaker-than-expected guidance; est. & PT chg.
elumeo published mixed Q4’23 that continue to be affected by a lingering
macroeconomic slowdown.
Here are our key takeaways:
The company’s FY sales were slightly better than feared, but still burdened
by muted consumer sentiment in the eurozone. Sales for FY came in fla [ … ]
Advertising is an important revenue channel for us. But we understand, that sometimes it becomes annoying. If you want to reduce the number of shown ADs just simply login to your useraccount and manage the settings from there. As registered user you get even more benefits.
We have summarised companies with a market capitalisation of more than EUR 1 billion that are not included in any index under X-Caps.
Dataselect Tool Family
boersengefluester.de · #BGFL
· © 2026
The news manufactory
Good luck with all your investments
Founded in 2013 by Gereon Kruse, the financial portal boersengefluester.de is all about German shares - with a clear focus on second-line stocks. In addition to traditional editorial articles, the site stands out in particular thanks to a large number of self-developed analysis tools. All tools are based on a completely self-maintained database for more than 650 shares. As a result, boersengefluester.de produces Germany's largest profit and dividend forecast.
Contact
Idea & concept: 3R Technologies 
boersengefluester.de GmbH
Copyright © 2026
by Gereon Kruse
#BGFL